Trademark Overview
On Wednesday, July 9, 2025, a trademark application was filed for SELITON with the United States Patent and Trademark Office. The USPTO has given the SELITON trademark a serial number of 99275193. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 9, 2025. This trademark is owned by Newcastle Bioscience, LLC. The SELITON trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations used to treat one or more of the following: infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, psychiatric conditions, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions